Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours
Open Access
- 26 May 2020
- journal article
- research article
- Published by Springer Nature in International Orthopaedics
- Vol. 44 (8) , 1503-1509
Abstract
Background: The aim of the current study was to evaluate the impact of the coronavirus disease (COVID-19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians. Methods: The survey was conducted among the members of the ISOLS (International Society of Limb Salvage) and the EMSOS (European Musculo-Skeletal Oncology Society). The survey consisted of 20 questions (single, multiple-response, ranked): origin and surgical experience of the participant (four questions), potential disruption of healthcare (12 questions), and influence of the COVID-19 pandemic on the particular physician (four questions). A matrix with four different response options was created for the particular surgical procedures). Results: One hundred forty-nine physicians from five continents completed the survey. Of the respondents, 20.1% and 20.7% stated that surgery for life-threatening sarcomas were stopped or delayed, respectively. Even when the malignancy was expected to involve infiltration of a neurovascular bundle or fracture of a bone, still 13.8% and 14.7% of the respondents, respectively, stated that surgery was not performed. In cases of pending fractures of bone tumors, 37.5 to 46.2% of operations were canceled. Conclusion: The SARS-CoV-2 pandemic caused a significant reduction in healthcare (surgery, radiotherapy, chemotherapy) for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life-threatening or can cause severe morbidity, pain, and loss of function. Although the coronavirus disease causes severe medical complications, serious collateral damage including death due to delayed or untreated sarcomas should be avoided.Keywords
Funding Information
- University of Innsbruck and Medical University of Innsbruck
This publication has 16 references indexed in Scilit:
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Analysis of Nondiagnostic Results after Image-guided Needle Biopsies of Musculoskeletal LesionsClinical Orthopaedics and Related Research, 2010
- In Brief: Classifications in BriefClinical Orthopaedics and Related Research, 2010
- Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature reviewAnnals of Oncology, 2009
- Active Unicameral Bone Cysts in the Upper Limb are at Greater Risk of FractureJournal of Orthopaedic Surgery, 2009
- Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesionsSkeletal Radiology, 2002
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001
- The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*Journal of Bone and Joint Surgery, 1996
- Bone cancersCancer, 1995
- The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.Journal of Bone and Joint Surgery, 1982